Australia markets open in 7 hours 14 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0154+0.0005 (+3.02%)
As of 12:28PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
18,218
18,218
16,837
8,244
446
Cost of revenue
6,512
6,512
4,415
4,055
468
Gross profit
11,706
11,706
12,422
4,189
-22
Operating expenses
Research development
2,939
2,939
25,032
33,129
17,050
Selling general and administrative
26,614
26,614
71,514
137,861
86,552
Total operating expenses
29,553
29,553
96,546
170,990
103,602
Operating income or loss
-17,847
-17,847
-84,124
-166,801
-103,624
Total other income/expenses net
70,812
70,812
7,385
-38,389
-38,850
Income before tax
52,996
52,996
-76,654
-205,175
-142,305
Income tax expense
17
17
44
17
4
Income from continuing operations
52,979
52,979
-76,698
-205,192
-142,309
Net income
52,979
52,979
-76,698
-205,192
-142,309
Net income available to common shareholders
49,995
49,995
-78,014
-206,239
-142,309
Basic EPS
60.30
-
-167.42
-2.95k
-3.97k
Diluted EPS
38.97
-
-167.42
-2.95k
-3.97k
Basic average shares
2,117
-
465.967
69.818
35.817
Diluted average shares
521,146
-
465.967
69.818
35.817